Zepbound, the new GLP-1 weight-loss drug from Eli Lilly & Co., has been approved by the Food and Drug Administration for ...
The FDA said studies have shown that by aiding weight loss, Zepbound improves sleep apnea symptoms in some patients.
The US Food and Drug Administration on Friday approved the first prescription medicine for obstructive sleep apnea: the ...
This weight-loss drug, designed for obese patients, significantly reduces breathing disruptions and offers a new treatment ...
The Senate’s approval came shortly after the shutdown deadline. President Biden was expected to sign the bill, and preparations to close government agencies were called off. Trump Wanted ...
Senate Prepares to Vote on Stopgap Funding Bill Hours Ahead of Shutdown Deadline Chuck Schumer, the Senate majority leader, said the new legislation will likely pass quickly, and President Biden ...